The CIC biomaGUNE Center for Cooperative Research in Biomaterials has introduced a novel system named epiGPTope, aimed at advancing vaccine and immunotherapy research.
This innovative tool facilitates the screening of millions of tiny protein fragments, allowing researchers to pinpoint those that can be effectively recognized by the immune system.
The implications of this technology extend to the development of more targeted biosensors, potentially improving diagnostic and therapeutic strategies in immunology.